HomeComparePROCF vs SBUX

PROCF vs SBUX: Dividend Comparison 2026

PROCF yields 1818.18% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PROCF wins by $4103414683.67M in total portfolio value
10 years
PROCF
PROCF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full PROCF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — PROCF vs SBUX

📍 PROCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPROCFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PROCF + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PROCF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PROCF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, PROCF beats the other by $3,147,377,270,382,480.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PROCF + SBUX for your $10,000?

PROCF: 50%SBUX: 50%
100% SBUX50/50100% PROCF
Portfolio after 10yr
$2051707342.00M
Annual income
$1,851,398,394,413,771.80/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

PROCF
No analyst data
Altman Z
0.4
Piotroski
6/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PROCF buys
0
SBUX buys
0
No recent congressional trades found for PROCF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPROCFSBUX
Forward yield1818.18%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$4103414683.84M$167.0K
Annual income after 10y$3,702,796,788,756,407.00$71,136.45
Total dividends collected$4074760433.31M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: PROCF vs SBUX ($10,000, DRIP)

YearPROCF PortfolioPROCF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$192,518$181,818.18$11,121$420.68+$181.4KPROCF
2$3,477,331$3,271,336.99$12,548$648.40+$3.46MPROCF
3$58,943,217$55,222,471.89$14,440$1,013.98+$58.93MPROCF
4$937,891,469$874,822,227.57$17,068$1,617.30+$937.87MPROCF
5$14,012,869,532$13,009,325,660.38$20,912$2,649.52+$14012.85MPROCF
6$196,647,994,247$181,654,223,846.76$26,875$4,499.29+$196647.97MPROCF
7$2,592,865,386,485$2,382,452,032,641.56$36,771$8,014.12+$2592865.35MPROCF
8$32,132,661,421,271$29,358,295,457,731.54$54,542$15,197.11+$32132661.37MPROCF
9$374,409,247,740,494$340,027,300,019,734.44$89,602$31,242.49+$374409247.65MPROCF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$167,011$71,136.45+$4103414683.67MPROCF

PROCF vs SBUX: Complete Analysis 2026

PROCFStock

Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory. It also provides drugs for hospital use, such as antibiotic, blood clot, personal protective equipment, immunosuppressant, oncology, and analgesics products. In addition, the company offers over-the-counter (OTC) consumer healthcare products through a portfolio on approximately eight therapeutic areas, including gastrointestinal, skin care, cough and cold, analgesics, urological, vitamins, minerals, and supplements in the categories of antibiotics, anti-infective, anti-parasitic, cardiovascular, feminine care, cutaneous antimycotic, pain killers, gastro intestinal, hormonals, metabolic, endocrine, nervous system, ophthalmic, osteoarticular, respiratory, diet supplements, and vitamins and minerals. Further, it provides blood glucose meters, telemonitoring products, oral anti-diabetics products, cosmeceuticals, insulin delivery systems, and other diabetes solutions; and contract drug development and manufacturing services to third party pharmaceutical companies, specializing in soft gelatin capsule technologies. The company was founded in 1977 and is based in Luxembourg, Luxembourg.

Full PROCF Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this PROCF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PROCF vs SCHDPROCF vs JEPIPROCF vs OPROCF vs KOPROCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.